Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Capital Employed (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Return on Capital Employed for 13 consecutive years, with 0.05% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 4.0% year-over-year to 0.05%, compared with a TTM value of 0.05% through Oct 2025, up 4.0%, and an annual FY2025 reading of 0.05%, up 3.0% over the prior year.
  • Return on Capital Employed was 0.05% for Q4 2025 at Pharma-Bio Serv, up from 0.05% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.08% in Q1 2021 and bottomed at 0.21% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.03%, with a median of 0.04% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -27bps in 2022, then increased 29bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.16% in 2021, then surged by 139bps to 0.06% in 2022, then fell by -3bps to 0.06% in 2023, then crashed by -243bps to 0.09% in 2024, then soared by 40bps to 0.05% in 2025.
  • Business Quant data shows Return on Capital Employed for PBSV at 0.05% in Q4 2025, 0.05% in Q3 2025, and 0.05% in Q2 2025.